These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 12120695)
1. Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis. Erkut ZA; Endert E; Huitinga I; Swaab DF Mult Scler; 2002 May; 8(3):229-36. PubMed ID: 12120695 [TBL] [Abstract][Full Text] [Related]
2. The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Huitinga I; Erkut ZA; van Beurden D; Swaab DF Ann N Y Acad Sci; 2003 May; 992():118-28. PubMed ID: 12794052 [TBL] [Abstract][Full Text] [Related]
3. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Melief J; de Wit SJ; van Eden CG; Teunissen C; Hamann J; Uitdehaag BM; Swaab D; Huitinga I Acta Neuropathol; 2013 Aug; 126(2):237-49. PubMed ID: 23812288 [TBL] [Abstract][Full Text] [Related]
4. Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis? Akcali A; Zengin F; Aksoy SN; Zengin O Mult Scler Relat Disord; 2017 Jul; 15():37-41. PubMed ID: 28641771 [TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis. Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369 [TBL] [Abstract][Full Text] [Related]
7. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. Maimone D; Gregory S; Arnason BG; Reder AT J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study. Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557 [TBL] [Abstract][Full Text] [Related]
10. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis. Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029 [TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment. Limone P; Ferrero B; Calvelli P; Del Rizzo P; Rota E; Berardi C; Barberis AM; Isaia GC; Durelli L Acta Neurol Scand; 2002 May; 105(5):372-7. PubMed ID: 11982488 [TBL] [Abstract][Full Text] [Related]
12. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients. Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905 [TBL] [Abstract][Full Text] [Related]
13. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Hauser SL; Doolittle TH; Lincoln R; Brown RH; Dinarello CA Neurology; 1990 Nov; 40(11):1735-9. PubMed ID: 2234430 [TBL] [Abstract][Full Text] [Related]
14. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis. Kern S; Schultheiss T; Schneider H; Schrempf W; Reichmann H; Ziemssen T Psychoneuroendocrinology; 2011 Nov; 36(10):1505-12. PubMed ID: 21621332 [TBL] [Abstract][Full Text] [Related]
15. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898 [TBL] [Abstract][Full Text] [Related]
16. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8. Kleine TO; Zwerenz P; Graser C; Zöfel P Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. Silveira RC; Procianoy RS J Pediatr; 2003 Nov; 143(5):625-9. PubMed ID: 14615734 [TBL] [Abstract][Full Text] [Related]
18. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation. Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430 [TBL] [Abstract][Full Text] [Related]
19. Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Baraczka K; Nékám K; Pozsonyi T; Szüts I; Ormos G Eur J Neurol; 2004 Jan; 11(1):37-42. PubMed ID: 14692886 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. Drulović J; Mostarica-Stojković M; Lević Z; Stojsavljević N; Pravica V; Mesaros S J Neurol Sci; 1997 Apr; 147(2):145-50. PubMed ID: 9106119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]